SCHEMBL18200435

SCHEMBL18200435

c1ccc2c(c1)ccc1c(-c3ccc(-c4ccc(-c5cn6ccccc6n5)cc4)cc3)nc3ccccc3c12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 12/20 0.50
▸ NPC1 O15118 11/20 0.50
▸ KDM4E B2RXH2 9/20 0.50
▸ POLB P06746 2/20 0.50
▸ GFER P55789 3/20 0.49
▸ ALDH1A1 P00352 7/20 0.47
▸ SMN1; SMN2 Q16637 6/20 0.47
▸ PKM P14618 5/20 0.47
▸ MAPK1 P28482 3/20 0.47
▸ EPHX2 P34913 1/20 0.47
▸ HDAC6 Q9UBN7 1/20 0.45
▸ PTGS1 P23219 1/20 0.45
▸ PTGS2 P35354 1/20 0.45
▸ MEN1 O00255 1/20 0.44
▸ GAA P10253 1/20 0.44
▸ MIF P14174 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ MAPT P10636 3/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ ALDH1A3 P47895 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18200439 0.92 BACE1 (0.49) RAB9ANPC1KDM4EPOLBGFER
SCHEMBL18201097 0.92 BACE1 (0.47) RAB9ANPC1KDM4EPOLBGFER
SCHEMBL18200436 0.88 ALDH1A3 (0.60) RAB9ANPC1KDM4EPOLBALDH1A1
SCHEMBL18200437 0.88 SCD (0.46) RAB9ANPC1KDM4EPOLBALDH1A1
SCHEMBL18201096 0.88 BACE1 (0.51) RAB9ANPC1KDM4EPOLBGFER
SCHEMBL21934585 0.85 RAB9A (0.49) RAB9ANPC1KDM4EPOLBGFER
SCHEMBL22606579 0.85 RAB9A (0.44) RAB9ANPC1KDM4EPOLBGFER
SCHEMBL17915142 0.84 RAB9A (0.53) RAB9ANPC1KDM4EPOLBGFER
SCHEMBL22607078 0.84 RAB9A (0.50) RAB9ANPC1KDM4EPOLBGFER
SCHEMBL18845807 0.84 RAB9A (0.45) RAB9ANPC1KDM4EPOLBGFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 — — US disclosed
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 — — US disclosed
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2016-12-29 — — US disclosed
EP-3088392-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME Heesung Material Ltd. (KR) 2016-11-02 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME NOTUM, DDT, CRY1 RAB9A 2864/4885NPC1 3875/4885KDM4E 1977/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback